Visit clinicaltrials.gov, a database of privately and publicly funded clinical studies conducted around the world. Before participating in a study, talk to your health care provider and learn about the risks and potential benefits.
Current Opportunities:
Study of Mavorixafor in Participants with Severe Congenital Neutropenia and Chronic Neutropenia Disorders
This Phase 1b study will determine the safety and tolerability of mavorixafor in participants with severe chronic idiopathic neutropenia (CIN) and selected congenital neutropenia disorders. The anticipated enrollment is up…
X4 Pharacutical Phase 3 WHIM Trial
X4 Pharmaceutical’s (Cambridge, MA) Phase 3 WHIM trial is open now for enrollment, entitled “A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of mavorixafor (X4P-001) in Patients with WHIM Syndrome…
Free Genetic Testing for Congenital, Chronic, and/or Idiopathic Neutropenia
Free genetic testing is available for people living with congenital, chronic, and/or idiopathic neutropenia to help them learn more about their condition.There are 407 genes known to cause primary immune…
Learn More » Free Genetic Testing for Congenital, Chronic, and/or Idiopathic Neutropenia
PID panel testing to people who fit the symptomatic profile of WHIM syndrome
X4 is joining forces with ‘Probably Genetic’ to provide PID panel testing to people who fit the symptomatic profile of WHIM syndrome-a rare genetic immunodeficiency caused by mutations in the…
Learn More » PID panel testing to people who fit the symptomatic profile of WHIM syndrome
